Microbot Medical Inc (MBOT)

$2.54 -0.07 (-2.68%)
Market Cap 170.58M
Revenue (ttm) 0.00
Net Income (ttm) -11.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,335,800
Avg Vol 2,139,924
Day's Range N/A - N/A
Shares Out 67.16M
Stochastic %K 20%
Beta 1.22
Analysts Strong Sell
Price Target $7.50

Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides No...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 781 875 3605
Address:
175 Derby Street, Bld. 27, Hingham, United States
no_ego
no_ego Mar. 20 at 6:44 PM
$MBOT Holy Moley! I had a funny feeling that we would close expiration Friday at or below 2.50 and screw the call buyers. I bought back the ones I sold and made some, so I'm not complaining, but I was really on the fence at the time. Today isn't over yet, but a close right at 2.50 wouldn't be a surprise.
1 · Reply
Stratsys
Stratsys Mar. 20 at 1:38 PM
$MBOT
0 · Reply
Prash83
Prash83 Mar. 20 at 1:06 PM
$MBOT another company in Remote controlled stroke treatment done successful procedure! Competition is real!
2 · Reply
gladee88er
gladee88er Mar. 20 at 6:00 AM
$MBOT I still think one of the best things to come from the Emory testing is the fact the hospital is using the Liberty for multiple specialties like Oncology, Cardiology, and Vascular procedures. Gadot's exact words following the ISET conference were as follows: "We have seen increased interest from physicians across several specialties within the same account and network of hospitals, including interventional radiology, interventional oncology, vascular surgery and interventional cardiology, which we believe is reinforcing its broad clinical relevance." I'm guessing that must be at Emory. Although the Liberty is currently allowed to do most of those procedures under the "Peripheral" Umbrella, the exceptions are the heart (Coronary) and the brain (Neurovascular). Apparently the Liberty CAN treat a leg clot, but the system is not intended for coronary or neurointerventional procedures. The Liberty could steer into a coronary artery, but it's not supposed to.
1 · Reply
LestatN
LestatN Mar. 19 at 7:15 PM
$MBOT News of the conf today ?
0 · Reply
Stratsys
Stratsys Mar. 19 at 2:20 PM
$MBOT Buy opportunity
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 19 at 10:47 AM
$MBOT RSI: 53.17, MACD: 0.1602 Vol: 0.22, MA20: 2.49, MA50: 2.19 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DragonAlgo
DragonAlgo Mar. 19 at 8:06 AM
🐉 $MBOT PUT — DragonAlgo® Signal Contract: MBOT PUT Expiry: 2026-07-17 | Strike: $2.00 | Type: PUT Option Plan (premium): Entry: $0.32 Stop: $0.23 TP1: $0.42 TP2: $0.54 TP3: $0.77 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
zo_man
zo_man Mar. 18 at 5:49 PM
$MBOT Earnings is next week 3/24. This could be the first report with Revenue after soft launch last December… and possible projections for remainder of Y2026 with full launch starting April. Exciting times!!
2 · Reply
Quantum_Capital_LLC
Quantum_Capital_LLC Mar. 18 at 5:00 PM
$MBOT up 26% in the last 4 weeks; ER Tuesday 31March. If it can get above 2.85 by then, Bulls could see a nice move. Do your own DD. Glta.
0 · Reply
Latest News on MBOT
Microbot Medical® to Participate at the 38th Annual Roth Conference

Mar 17, 2026, 8:40 AM EDT - 4 days ago

Microbot Medical® to Participate at the 38th Annual Roth Conference

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

Mar 10, 2026, 8:30 AM EDT - 11 days ago

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

Mar 4, 2026, 8:30 AM EST - 17 days ago

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

Mar 3, 2026, 9:00 AM EST - 18 days ago

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System

Feb 24, 2026, 1:48 PM EST - 25 days ago

Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Feb 24, 2026, 8:30 AM EST - 25 days ago

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Feb 19, 2026, 8:30 AM EST - 4 weeks ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Feb 12, 2026, 8:30 AM EST - 5 weeks ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Feb 5, 2026, 8:30 AM EST - 6 weeks ago

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Jan 12, 2026, 8:30 AM EST - 2 months ago

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Nov 26, 2025, 8:30 AM EST - 4 months ago

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Nov 5, 2025, 8:30 AM EST - 4 months ago

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Oct 16, 2025, 8:30 AM EDT - 5 months ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Oct 14, 2025, 8:30 AM EDT - 5 months ago

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Oct 7, 2025, 8:00 AM EDT - 5 months ago

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Oct 1, 2025, 9:00 AM EDT - 6 months ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 23, 2025, 8:30 AM EDT - 6 months ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Sep 16, 2025, 3:37 PM EDT - 6 months ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 15, 2025, 8:00 AM EDT - 6 months ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 9, 2025, 8:28 AM EDT - 6 months ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Sep 8, 2025, 8:28 AM EDT - 6 months ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Aug 28, 2025, 3:57 PM EDT - 7 months ago

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 20, 2025, 8:30 AM EDT - 7 months ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Aug 5, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 22, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Microbot Medical® Added to the Russell Microcap® Index

Jun 30, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical® Added to the Russell Microcap® Index

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 17, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 9, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Jun 5, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 23, 2025, 8:30 AM EDT - 11 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 9, 2025, 8:30 AM EDT - 1 year ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Apr 1, 2025, 8:30 AM EDT - 1 year ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Mar 4, 2025, 8:30 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 25, 2025, 8:30 AM EST - 1 year ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 11, 2025, 6:15 PM EST - 1 year ago

Microbot Medical Closes $13 Million Registered Direct Offering

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Feb 10, 2025, 8:00 AM EST - 1 year ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 10, 2025, 10:25 AM EST - 1 year ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Jan 7, 2025, 4:15 PM EST - 1 year ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 30, 2024, 8:30 AM EST - 1 year ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Dec 10, 2024, 10:18 AM EST - 1 year ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

no_ego
no_ego Mar. 20 at 6:44 PM
$MBOT Holy Moley! I had a funny feeling that we would close expiration Friday at or below 2.50 and screw the call buyers. I bought back the ones I sold and made some, so I'm not complaining, but I was really on the fence at the time. Today isn't over yet, but a close right at 2.50 wouldn't be a surprise.
1 · Reply
Stratsys
Stratsys Mar. 20 at 1:38 PM
$MBOT
0 · Reply
Prash83
Prash83 Mar. 20 at 1:06 PM
$MBOT another company in Remote controlled stroke treatment done successful procedure! Competition is real!
2 · Reply
gladee88er
gladee88er Mar. 20 at 6:00 AM
$MBOT I still think one of the best things to come from the Emory testing is the fact the hospital is using the Liberty for multiple specialties like Oncology, Cardiology, and Vascular procedures. Gadot's exact words following the ISET conference were as follows: "We have seen increased interest from physicians across several specialties within the same account and network of hospitals, including interventional radiology, interventional oncology, vascular surgery and interventional cardiology, which we believe is reinforcing its broad clinical relevance." I'm guessing that must be at Emory. Although the Liberty is currently allowed to do most of those procedures under the "Peripheral" Umbrella, the exceptions are the heart (Coronary) and the brain (Neurovascular). Apparently the Liberty CAN treat a leg clot, but the system is not intended for coronary or neurointerventional procedures. The Liberty could steer into a coronary artery, but it's not supposed to.
1 · Reply
LestatN
LestatN Mar. 19 at 7:15 PM
$MBOT News of the conf today ?
0 · Reply
Stratsys
Stratsys Mar. 19 at 2:20 PM
$MBOT Buy opportunity
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 19 at 10:47 AM
$MBOT RSI: 53.17, MACD: 0.1602 Vol: 0.22, MA20: 2.49, MA50: 2.19 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DragonAlgo
DragonAlgo Mar. 19 at 8:06 AM
🐉 $MBOT PUT — DragonAlgo® Signal Contract: MBOT PUT Expiry: 2026-07-17 | Strike: $2.00 | Type: PUT Option Plan (premium): Entry: $0.32 Stop: $0.23 TP1: $0.42 TP2: $0.54 TP3: $0.77 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
zo_man
zo_man Mar. 18 at 5:49 PM
$MBOT Earnings is next week 3/24. This could be the first report with Revenue after soft launch last December… and possible projections for remainder of Y2026 with full launch starting April. Exciting times!!
2 · Reply
Quantum_Capital_LLC
Quantum_Capital_LLC Mar. 18 at 5:00 PM
$MBOT up 26% in the last 4 weeks; ER Tuesday 31March. If it can get above 2.85 by then, Bulls could see a nice move. Do your own DD. Glta.
0 · Reply
Love_To_Learn
Love_To_Learn Mar. 18 at 10:57 AM
$MBOT made a lil tweak to u as well following creating the market trend
1 · Reply
gladee88er
gladee88er Mar. 18 at 10:19 AM
$MBOT New 13F filing Heights Capital Management Inc. has bought a decent-sized stake in MBOT (883,104 shares). They now own 1.31% of the company.
2 · Reply
DragonAlgo
DragonAlgo Mar. 18 at 7:49 AM
🐉 $MBOT CALL — DragonAlgo® Signal Contract: MBOT CALL Expiry: 2026-04-17 | Strike: $2.50 | Type: CALL Option Plan (premium): Entry: $0.55 Stop: $0.40 TP1: $0.72 TP2: $0.94 TP3: $1.32 🔗 https://dragonalgo.com
0 · Reply
HorseShaq19
HorseShaq19 Mar. 18 at 7:25 AM
$MBOT Management’s language is direct…. ‘success,’ ‘validated strategy,’ ‘on target’… unambiguously positive for a team still in early commercialization. Rare confidence.
1 · Reply
gladee88er
gladee88er Mar. 18 at 1:05 AM
$MBOT If we finally break $2.86 again we're heading to $3+ tonight.
0 · Reply
Bdin42
Bdin42 Mar. 17 at 10:49 PM
$MBOT Here is the press release and presentation for the upcoming Roth conference next week. Worth the read - https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=319874834&type=HTML&symbol=MBOT&cdn=7b8bbc627254cb2a3a1dd89eb922acd8&companyName=Microbot+Medical+Inc.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2026-03-17
0 · Reply
StocksGoddess
StocksGoddess Mar. 17 at 8:00 PM
$MBOT is going to fly.
2 · Reply
Packland
Packland Mar. 17 at 5:53 PM
$MBOT green
0 · Reply
FLNY
FLNY Mar. 17 at 4:34 PM
$MBOT Let's turn this green today.
0 · Reply
no_ego
no_ego Mar. 17 at 2:58 PM
$MBOT Ok, I'm going to make a bold prediction solely based on this chart. Twice now we have hit the bottom of this channel then popped to the top. I even tempted fate by selling 2.50 calls after that pop from 2.10 to over 2.50, then bought them back for less on the pullback to the 2.30's. That was a gutsy, aka stupid, move all based on that chart, and it works completely as expected. If this pattern hold true, I suspect we stay in this 2.70 area for another 2 or 3 days then pop again when we get to the bottom of the channel. I say Friday or Monday we get into the 3's. However, I reserve the right to be wrong!
2 · Reply
gladee88er
gladee88er Mar. 17 at 2:52 PM
$MBOT This morning's 8-K mentioned "multi-site customer adoption. They are suggesting that Tampa isn't the only one in the pipeline. Hope we get some good news on Monday as well as from the Oppenheimer Conference.
0 · Reply
gladee88er
gladee88er Mar. 17 at 2:28 PM
$MBOT Looks like we're a little flat coming into Thursday mornings speech at the Oppenheimer Conference. If there's a mention of a new hospital, or any details on the Full Market Release, we could be looking at $3.50 again , at least for a hot minute.
0 · Reply